Drugs For Schistosomiasis Market By Drug Type (Artemisinins, Biltricide, Corticosteroids, Metrifonate, Trioxolanes, Praziquantel, Oxamniquine, Others) By Application (Schistosoma Guineensis, Schistosoma Haematobium, Schistosoma Intercalatum, Schistosoma Japonicum, Schistosoma Mansoni, Schistosoma Mekongi) By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)- Growth, Size, Share and Competitive Analysis 2015 – 2027

Market Insights:

The Drugs for Schistosomiasis market is estimated to reach at USD 103.4 million in 2027 from USD 73.4 million in 2020. The market is anticipated to grow at a CAGR of 5.6% during the forecast timeline.

Schistosomiasis is an infection acquired by people while coming into contact with the water-containing larva of schistosomes. The adult form of the worms lives inside the intestines and urinary tracts of humans. According to the World Health Organization, nearly 200000 people die due to schistosomiasis annually. The “Global Drugs for Schistosomiasis Market” offers comprehensive and precise insights on this market.

Key Market Drivers and Restraints

This report includes detailed analysis of factors expected to fuel the growth of Drugs for Schistosomiasis market. Moreover, it also covered the major factors likely to hamper the market growth and helps in identifying growth pockets.

Impact of COVID 19

COVID 19 has significantly impacted the global Drugs for Schistosomiasis market. It affected the demand and sales of Drugs for Schistosomiasis, as hospitals put more emphasis on the treatment of COVID 19 patients. It affected the detection and treatment of Schistosomiasis. Global Drugs for Schistosomiasis market reported around 19.2% decline in its revenue as compared to 2019. With the COVID 19 cases decreasing significantly around the world, the global Drugs for Schistosomiasis market is anticipated to regain its pre-COVID 19 levels soon.

North America is expected to lead the global Drugs for Schistosomiasis market

The global Drugs for Schistosomiasis market is segmented into six geographies with all major economies pertaining to it. The report offers a comprehensive insight on major regional markets. By Region, North America is expected to lead the global market throughout the forecast period by holding 28.9% revenue share in 2020.

Global Drugs for Schistosomiasis Market is dominated by the demand for Praziquantel     

Biltricide, Artemisinins, Metrifonate, Oxamniquine and Praziquantel are the major drugs for schistosomiasis. However, Praziquantel is the most effective drug available in the market for different species of Schistosoma. It accounted for the vast majority of the revenue generated in the Drugs for Schistosomiasis market with a share of over 25% in 2020. There are many pipeline drugs in the clinical trial stage.

The increasing number of schistosomiasis patients drives the global demand for Drugs for Schistosomiasis

The improving healthcare facilities in developing countries around the world is increasing the number of detections of schistosomiasis patients. Increasing pollution in rivers, lakes, and ponds in tropical and sub-tropical countries is providing breeding grounds for Schistosoma species that cause the infection. Nearly 700 million people live in endemic countries and it increases the risk of infection.  Africa and the Middle East account for 42.1% share of the total revenue generated by the global Drugs for Schistosomiasis industry.

Frequently asked questions about global Drugs for Schistosomiasis industry

• What are the consequences of COVID 19 on global Drugs for Schistosomiasis industry?
  Ans: The report offers in-depth consequences of COVID 19 on global Drugs for Schistosomiasis industry

• Who are the top five players in the global Drugs for Schistosomiasis industry?
  Ans: This report enlists the top five players on the basis of volume as well as revenue

• Which is the fastest growing application market for global Drugs for Schistosomiasis industry?
  Ans: This report provides details of fastest growing application market for Drugs for Schistosomiasis industry

• Which is the leading regional market for global Drugs for Schistosomiasis industry?
  Ans: The report highlights most dominating as well as fastest growing economies for Drugs for Schistosomiasis industry

• What will be the CAGR (2021 - 2027) of in global Drugs for Schistosomiasis industry?
  Ans: The global Drugs for Schistosomiasis market report provide CAGR from 2021 to 2027

• What was the volume and revenue of global Drugs for Schistosomiasis industry in 2015?
  Ans: This report provides detailed market size, share and growth for historical period from 2015 to 2020

• Which are the growing technological trends in in global Drugs for Schistosomiasis industry?
  Ans: The report helps to identify the key technological trends Drugs for Schistosomiasis industry across the world

• Which are the major driving forces behind growth of global Drugs for Schistosomiasis industry?
  Ans: The report covers all major factors fueling the growth of this industry

• What are the key growth pockets within global Drugs for Schistosomiasis industry?
  Ans: The report also reveals key growth pockets within global Drugs for Schistosomiasis industry

• What are the attractive investment prepositions in the global Drugs for Schistosomiasis industry?
  Ans: Global Drugs for Schistosomiasis market report provides key investment prepositions based on types, applications and regions

• What are the key challenges faced by the industry participants in global Drugs for Schistosomiasis market?
  Ans: This report answers major challenges being faced by the global Drugs for Schistosomiasis players

• What is the competitive scenario in global Drugs for Schistosomiasis industry?
  Ans: The report describes in detailed about current competitive scenario of Drugs for Schistosomiasis industry

• Which are the major production geographies?
  Ans: The report covers the major production geographies for Drugs for Schistosomiasis industry

• Who are the major regulatory bodies in global Drugs for Schistosomiasis industry?
  Ans: The report provides insights related to major regulatory bodies in global Drugs for Schistosomiasis industry

• Which are the major companies governing the global Drugs for Schistosomiasis industry?
  Ans: This report enlists the top five players on the basis of volume as well as revenue

Table of Content

1.Preface

1.1.Report Description
1.1.1.Purpose of the Report
1.1.2.Target Audience
1.1.3.USP and Key Offerings
1.2.Research Scope
1.3.Research Methodology
1.3.1.Phase I – Secondary Research
1.3.2.Phase II – Primary Research
1.3.3.Phase III – Expert Panel Review
1.3.4.Approach Adopted
1.3.4.1.Top-Down Approach
1.3.4.2.Bottom-Up Approach
1.3.5.Assumptions
1.4.Market Segmentation

2.Executive Summary

2.1.Market Snapshot: Global Drugs for Schistosomiasis Market

3.Market Dynamics

3.1.Introduction
3.1.1. Global Drugs for Schistosomiasis Market Value, 2015-2027, (US$ Bn)
3.2.Market Dynamics
3.2.1.Key Growth Trends
3.2.2.Major Industry Challenges
3.2.3.Key Growth Pockets
3.3.Attractive Investment Proposition, 2020
3.3.1.Drug Type
3.3.2.Application
3.3.3.Distribution Channel
3.3.4.Geography

4.Market Positioning of Key Players, 2020

4.1.Company market share of key players, 2020
4.2.Top 6 Players
4.3.Top 3 Players
4.4.Major Strategies Adopted by Key Players

5.COVID 19 Impact Analysis

5.1.Global Drugs for Schistosomiasis Market Pre Vs Post COVID 19, 2019 - 2027
5.2.Impact on Import & Export
5.3.Impact on Demand & Supply

6.North America

6.1.North America Drugs for Schistosomiasis Market, by Country, 2015-2027 (US$ Bn)
6.1.1.U.S.
6.1.2.Canada
6.1.3.Mexico
6.2.North America Drugs for Schistosomiasis Market, by Drug Type, 2015-2027 (US$ Bn)
6.2.1.Overview
6.2.2.Artemisinins
6.2.3.Biltricide
6.2.4.Corticosteroids
6.2.5.Metrifonate
6.2.6.Trioxolanes
6.2.7.Praziquantel
6.2.8.Oxamniquine
6.2.9.Others
6.3.North America Drugs for Schistosomiasis Market, By Application, 2015-2027 (US$ Bn)
6.3.1.Overview
6.3.2.Schistosoma Guineensis
6.3.3.Schistosoma Haematobium
6.3.4.Schistosoma Intercalatum
6.3.5.Schistosoma Japonicum
6.3.6.Schistosoma Mansoni
6.3.7.Schistosoma Mekongi
6.4.North America Drugs for Schistosomiasis Market, by Distribution Channel, 2015-2027 (US$ Bn)
6.4.1.Overview
6.4.2.Hospital Pharmacy
6.4.3.Online Pharmacy
6.4.4.Retail Pharmacy

7.Europe

7.1.Europe Drugs for Schistosomiasis Market, by Country, 2015-2027 (US$ Bn)
7.1.1.UK
7.1.2.France
7.1.3.Germany
7.1.4.Italy
7.1.5.Russia
7.1.6.Spain
7.1.7.Belgium
7.1.8.Netherland
7.1.9.Austria
7.1.10.Sweden
7.1.11.Poland
7.1.12.Denmark
7.1.13.Switzerland
7.1.14.Rest of Europe
7.2.Europe Drugs for Schistosomiasis Market, by Drug Type, 2015-2027 (US$ Bn)
7.2.1.Overview
7.2.2.Artemisinins
7.2.3.Biltricide
7.2.4.Corticosteroids
7.2.5.Metrifonate
7.2.6.Trioxolanes
7.2.7.Praziquantel
7.2.8.Oxamniquine
7.2.9.Others
7.3.Europe Drugs for Schistosomiasis Market, By Application, 2015-2027 (US$ Bn)
7.3.1.Overview
7.3.2.Schistosoma Guineensis
7.3.3.Schistosoma Haematobium
7.3.4.Schistosoma Intercalatum
7.3.5.Schistosoma Japonicum
7.3.6.Schistosoma Mansoni
7.3.7.Schistosoma Mekongi
7.4.Europe Drugs for Schistosomiasis Market, by Distribution Channel, 2015-2027 (US$ Bn)
7.4.1.Overview
7.4.2.Hospital Pharmacy
7.4.3.Online Pharmacy
7.4.4.Retail Pharmacy

8.Asia Pacific

8.1.Asia Pacific Drugs for Schistosomiasis Market, by Country, 2015-2027 (US$ Bn)
8.1.1.China
8.1.2.Japan
8.1.3.South Korea
8.1.4.India
8.1.5.Australia
8.1.6.New Zealand
8.1.7.Taiwan
8.1.8.Southeast Asia
8.1.9.Central Asia
8.1.10.Rest of Asia Pacific
8.2.Asia Pacific Drugs for Schistosomiasis Market, by Drug Type, 2015-2027 (US$ Bn)
8.2.1.Overview
8.2.2.Artemisinins
8.2.3.Biltricide
8.2.4.Corticosteroids
8.2.5.Metrifonate
8.2.6.Trioxolanes
8.2.7.Praziquantel
8.2.8.Oxamniquine
8.2.9.Others
8.3.Asia Pacific Drugs for Schistosomiasis Market, By Application, 2015-2027 (US$ Bn)
8.3.1.Overview
8.3.2.Schistosoma Guineensis
8.3.3.Schistosoma Haematobium
8.3.4.Schistosoma Intercalatum
8.3.5.Schistosoma Japonicum
8.3.6.Schistosoma Mansoni
8.3.7.Schistosoma Mekongi
8.4.Asia Pacific Drugs for Schistosomiasis Market, by Distribution Channel, 2015-2027 (US$ Bn)
8.4.1.Overview
8.4.2.Hospital Pharmacy
8.4.3.Online Pharmacy
8.4.4.Retail Pharmacy

9.Latin America

9.1.Latin America Drugs for Schistosomiasis Market, by Country, 2015-2027 (US$ Bn)
9.1.1.Brazil
9.1.2.Argentina
9.1.3.Peru
9.1.4.Chile
9.1.5.Colombia
9.1.6.Rest of Latin America
9.2.Latin America Drugs for Schistosomiasis Market, by Drug Type, 2015-2027 (US$ Bn)
9.2.1.Overview
9.2.2.Artemisinins
9.2.3.Biltricide
9.2.4.Corticosteroids
9.2.5.Metrifonate
9.2.6.Trioxolanes
9.2.7.Praziquantel
9.2.8.Oxamniquine
9.2.9.Others
9.3.Latin America Drugs for Schistosomiasis Market, By Application, 2015-2027 (US$ Bn)
9.3.1.Overview
9.3.2.Schistosoma Guineensis
9.3.3.Schistosoma Haematobium
9.3.4.Schistosoma Intercalatum
9.3.5.Schistosoma Japonicum
9.3.6.Schistosoma Mansoni
9.3.7.Schistosoma Mekongi
9.4.Latin America Drugs for Schistosomiasis Market, by Distribution Channel, 2015-2027 (US$ Bn)
9.4.1.Overview
9.4.2.Hospital Pharmacy
9.4.3.Online Pharmacy
9.4.4.Retail Pharmacy

10.Middle East

10.1.Middle East Drugs for Schistosomiasis Market, by Country, 2015-2027 (US$ Bn)
10.1.1.UAE
10.1.2.KSA
10.1.3.Israel
10.1.4.Turkey
10.1.5.Iran
10.1.6.Rest of Middle East
10.2.Middle East Drugs for Schistosomiasis Market, by Drug Type, 2015-2027 (US$ Bn)
10.2.1.Overview
10.2.2.Artemisinins
10.2.3.Biltricide
10.2.4.Corticosteroids
10.2.5.Metrifonate
10.2.6.Trioxolanes
10.2.7.Praziquantel
10.2.8.Oxamniquine
10.2.9.Others
10.3.Middle East Drugs for Schistosomiasis Market, By Application, 2015-2027 (US$ Bn)
10.3.1.Overview
10.3.2.Schistosoma Guineensis
10.3.3.Schistosoma Haematobium
10.3.4.Schistosoma Intercalatum
10.3.5.Schistosoma Japonicum
10.3.6.Schistosoma Mansoni
10.3.7.Schistosoma Mekongi
10.4.Middle East Drugs for Schistosomiasis Market, by Distribution Channel, 2015-2027 (US$ Bn)
10.4.1.Overview
10.4.2.Hospital Pharmacy
10.4.3.Online Pharmacy
10.4.4.Retail Pharmacy

11.Africa

11.1.Africa Drugs for Schistosomiasis Market, by Country, 2015-2027 (US$ Bn)
11.1.1.South Africa
11.1.2.Egypt
11.1.3.Nigeria
11.1.4.Rest of Africa
11.2.Africa Drugs for Schistosomiasis Market, by Drug Type, 2015-2027 (US$ Bn)
11.2.1.Overview
11.2.2.Artemisinins
11.2.3.Biltricide
11.2.4.Corticosteroids
11.2.5.Metrifonate
11.2.6.Trioxolanes
11.2.7.Praziquantel
11.2.8.Oxamniquine
11.2.9.Others
11.3.Africa Drugs for Schistosomiasis Market, By Application, 2015-2027 (US$ Bn)
11.3.1.Overview
11.3.2.Schistosoma Guineensis
11.3.3.Schistosoma Haematobium
11.3.4.Schistosoma Intercalatum
11.3.5.Schistosoma Japonicum
11.3.6.Schistosoma Mansoni
11.3.7.Schistosoma Mekongi
11.4.Africa Drugs for Schistosomiasis Market, by Distribution Channel, 2015-2027 (US$ Bn)
11.4.1.Overview
11.4.2.Hospital Pharmacy
11.4.3.Online Pharmacy
11.4.4.Retail Pharmacy

12.Global

12.1.Global Drugs for Schistosomiasis Market, by Drug Type, 2015-2027 (US$ Bn)
12.1.1.Overview
12.1.2.Artemisinins
12.1.3.Biltricide
12.1.4.Corticosteroids
12.1.5.Metrifonate
12.1.6.Trioxolanes
12.1.7.Praziquantel
12.1.8.Oxamniquine
12.1.9.Others
12.2.Global Drugs for Schistosomiasis Market, By Application, 2015-2027 (US$ Bn)
12.2.1.Overview
12.2.2.Schistosoma Guineensis
12.2.3.Schistosoma Haematobium
12.2.4.Schistosoma Intercalatum
12.2.5.Schistosoma Japonicum
12.2.6.Schistosoma Mansoni
12.2.7.Schistosoma Mekongi
12.3.Global Drugs for Schistosomiasis Market, by Distribution Channel, 2015-2027 (US$ Bn)
12.3.1.Overview
12.3.2.Hospital Pharmacy
12.3.3.Online Pharmacy
12.3.4.Retail Pharmacy
12.3.5.

13.Company Profiles

13.1.Bayer AG
13.2.Chandra Bhagat Pharma Ltd
13.3.EIPICO
13.4.Merck & Co Inc
13.5.Pfizer Inc
13.6.Par Pharmaceutical Inc
13.7.Samarth Pharma Pvt Ltd
13.8.Sanofi SA
13.9.Shin Poong Pharm Co Ltd
13.10. Taj Pharmaceuticals Ltd

List of Figures

FIG. 1 Global Drugs for Schistosomiasis Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Drugs for Schistosomiasis Market Segmentation
FIG. 4 Global Drugs for Schistosomiasis Market, by Drug Type 2019 (US$ Bn)
FIG. 5 Global Drugs for Schistosomiasis Market, by Drug Application 2019 (US$ Bn)
FIG. 6 Global Drugs for Schistosomiasis Market, by Distribution Channel, 2019 (US$ Bn)
FIG. 7 Global Drugs for Schistosomiasis Market, by Geography, 2019 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Geography, 2019
FIG. 9 Global Market Positioning of Key Drugs for Schistosomiasis Market Manufacturers, 2019
FIG. 10 Global Drugs for Schistosomiasis Market Value Contribution, By Drug Type, 2019 & 2027 (Value %)
FIG. 11 Global Drugs for Schistosomiasis Market, by Drug 1, Value, 2015-2027 (US$ Bn)
FIG. 12 Global Drugs for Schistosomiasis Market, by Drug 2, Value, 2015-2027 (US$ Bn)
FIG. 13 Global Drugs for Schistosomiasis Market, by Drug 3, Value, 2015-2027 (US$ Bn)
FIG. 14 Global Drugs for Schistosomiasis Market, by Drug 4, Value, 2015-2027 (US$ Bn)
FIG. 15 Global Drugs for Schistosomiasis Market, by Drug 5, Value, 2015-2027 (US$ Bn)
FIG. 16 Global Drugs for Schistosomiasis Market, by Others, Value, 2015-2027 (US$ Bn)
FIG. 17 Global Drugs for Schistosomiasis Market Value Contribution, By Application, 2019 & 2027 (Value %)
FIG. 18 Global Drugs for Schistosomiasis Market, by Application 1, Value, 2015-2027 (US$ Bn)
FIG. 19 Global Drugs for Schistosomiasis Market, by Application 2, Value, 2015-2027 (US$ Bn)
FIG. 20 Global Drugs for Schistosomiasis Market, by Application 3, Value, 2015-2027 (US$ Bn)
FIG. 21 Global Drugs for Schistosomiasis Market, by Application 4, Value, 2015-2027 (US$ Bn)
FIG. 22 Global Drugs for Schistosomiasis Market, by Application 5, Value, 2015-2027 (US$ Bn)
FIG. 23 Global Drugs for Schistosomiasis Market, by Others, Value, 2015-2027 (US$ Bn)
FIG. 24 Global Drugs for Schistosomiasis Market Value Contribution, By Distribution Channel, 2019 & 2027 (Value %)
FIG. 25 Global Drugs for Schistosomiasis Market, by Channel 1, Value, 2015-2027 (US$ Bn)
FIG. 26 Global Drugs for Schistosomiasis Market, by Channel 2, Value, 2015-2027 (US$ Bn)
FIG. 27 Global Drugs for Schistosomiasis Market, by Channel 3, Value, 2015-2027 (US$ Bn)
FIG. 28 U.S. Drugs for Schistosomiasis Market, 2015-2027 (US$ Bn)
FIG. 29 Rest of North America Drugs for Schistosomiasis Market, 2015-2027 (US$ Bn)
FIG. 30 U.K. Drugs for Schistosomiasis Market, 2015-2027 (US$ Bn)
FIG. 31 Germany Drugs for Schistosomiasis Market, 2015-2027 (US$ Bn)
FIG. 32 France Drugs for Schistosomiasis Market, 2015-2027 (US$ Bn)
FIG. 33 Rest of Europe Drugs for Schistosomiasis Market, 2015-2027 (US$ Bn)
FIG. 34 Japan Drugs for Schistosomiasis Market, 2015-2027 (US$ Bn)
FIG. 35 China Drugs for Schistosomiasis Market, 2015-2027 (US$ Bn)
FIG. 36 India Drugs for Schistosomiasis Market, 2015-2027 (US$ Bn)
FIG. 37 Rest of Asia Pacific Drugs for Schistosomiasis Market, 2015-2027 (US$ Bn)
FIG. 38 Middle East & Africa Drugs for Schistosomiasis Market, 2015-2027 (US$ Bn)
FIG. 39 Latin America Drugs for Schistosomiasis Market, 2015-2027 (US$ Bn)

TABLE 1 Market Snapshot: Global Drugs for Schistosomiasis Market
TABLE 2 Global Drugs for Schistosomiasis Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 3 Global Drugs for Schistosomiasis Market, by Application, 2015-2027 (US$ Bn)
TABLE 4 Global Drugs for Schistosomiasis Market, by Distribution Channel, 2015-2027 (US$ Bn)
TABLE 5 Global Drugs for Schistosomiasis Market, by Geography, 2015-2027 (US$ Bn)
TABLE 6 North America Drugs for Schistosomiasis Market, by Drug Type 2015-2027 (US$ Bn)
TABLE 7 North America Drugs for Schistosomiasis Market, by Application, 2015-2027 (US$ Bn)
TABLE 8 North America Drugs for Schistosomiasis Market, by Distribution Channel, 2015-2027 (US$ Bn)
TABLE 9 North America Drugs for Schistosomiasis Market, by Country, 2015-2027 (US$ Bn)
TABLE 10 Europe Drugs for Schistosomiasis Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 11 Europe Drugs for Schistosomiasis Market, by Application, 2015-2027 (US$ Bn)
TABLE 12 Europe Drugs for Schistosomiasis Market, by Distribution Channel, 2015-2027 (US$ Bn)
TABLE 13 Europe Drugs for Schistosomiasis Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 14 Asia Pacific Drugs for Schistosomiasis Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 15 Asia Pacific Drugs for Schistosomiasis Market, by Application, 2015-2027 (US$ Bn)
TABLE 16 Asia Pacific Drugs for Schistosomiasis Market, by Distribution Channel, 2015-2027 (US$ Bn)
TABLE 17 Asia Pacific Drugs for Schistosomiasis Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 18 Latin America Drugs for Schistosomiasis Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 19 Latin America Drugs for Schistosomiasis Market, by Application, 2015-2027 (US$ Bn)
TABLE 20 Latin America Drugs for Schistosomiasis Market, by Distribution Channel, 2015-2027 (US$ Bn)
TABLE 21 Latin America Drugs for Schistosomiasis Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 22 Middle East Drugs for Schistosomiasis Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 23 Middle East Drugs for Schistosomiasis Market, by Application, 2015-2027 (US$ Bn)
TABLE 24 Middle East Drugs for Schistosomiasis Market, by Distribution Channel, 2015-2027 (US$ Bn)
TABLE 25 Middle East Drugs for Schistosomiasis Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 26 Africa Drugs for Schistosomiasis Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 27 Africa Drugs for Schistosomiasis Market, by Application, 2015-2027 (US$ Bn)
TABLE 28 Africa Drugs for Schistosomiasis Market, by Distribution Channel, 2015-2027 (US$ Bn)
TABLE 29 Africa Drugs for Schistosomiasis Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 30 Company 01: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 Company 2: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 Company 3: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 33 Company 4.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 34 Company 5: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 35 Company 6: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 36 Company 7: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 37 Company 8: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 38 Company 9: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 39 Company 10: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 40 Company 11: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 41 Company 12: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 42 Company 13: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments